ProtoKinetix, Inc.

ProtoKinetix, Incorporated is a research and development stage biotechnology company focused on scientific medical research into anti-freeze glycoproteins, trademarked as AAGPs. The entity works to commercially validate and advance the AAGP molecule for targeted healthcare solutions, including medical applications in preserving cells, tissues, and organs against stresses, as well as enhancing cell recovery from cryopreservation. Collaborating with researchers, commercial partners, contract research organizations, universities, and government agencies, the company aims to develop and test its proprietary technologies for potential clinical and commercial markets.

The company operates in the biotechnology sector without commercial sales, conducting product testing and pursuing commercialization partnerships primarily within North America. Its executive and corporate offices are located in Dalton, Ohio. Research and development activities rely on external collaborative agreements across the United States and Canada to advance its therapeutic formulations and cell preservation technologies toward eventual regulatory review and clinical trials.

Summary of the business section of ProtoKinetix's latest annual report, written by StockData.